Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-05-15 @ 7:53 AM
Study NCT ID:
NCT00488059
Status:
TERMINATED
Last Update Posted:
2011-07-22
First Post:
2007-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML20837
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Clinical Trials, Study Director
Old Organization:
Hoffmann-La Roche
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |